Sign in
CompletedNo phase

Impact of Antibio Prophylaxis on Occurence of Ventilator Associated Pneumonia in Trauma Patients

Key facts

Who runs it
Assistance Publique - Hôpitaux de Paris
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
2,143 people enrolled
Started
1 Nov 2024
Ended
31 Jul 2025
Type of study
Observational, 2 groups
Record updated
10 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult patient
  • Trauma patient: admitted between 01/01/2021 and 31/12/2023 for suspected severe trauma (included in TraumaBase® )
  • Put on mechanical ventilation during the first 24 hours following the start of medical care (including pre-hospital care)
  • Patient on MV for at least 48 consecutive hours during intensive care stay
  • Patient does not object to the use of his/her data for this research

Who cannot take part

  • Patient under full selective digestive decontamination protocol
  • Early inhaled antibiotic prophylaxis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The relevance of a short course of antibiotic prophylaxis for the prevention of ventilator assocaited pneumonia (VAP) in trauma patients, and its impact on bacterial ecology, remains to be clarified.

Read full original descriptionShow less

Antibiotics are often administered in the pre-hospital phase, usually in cases to traumatic lesions with high risk of secondary infection (open fractures, deteriorating wounds, etc.). If there is a potential benefit of such antibiotic prophylaxis on the risk of surgical site infection, there could also be a benefit on the risk of developing pulmonary infections. Recent data have shown a reduction in the risk of early-onset VAP in cerebrovascular patients with a strategy of very early administration of antibiotic prophylaxis (PROPHYVAP study(1)), as well as in patients taken into intensive care following cardiac arrest (ANTHARTIC study(2)). The aim of the study is to evaluate the impact of early systemic antibiotic prophylaxis in trauma patients on the incidence of early VAP during the ICU stay.

The 2 groups in the trial

  • Early antibiotic prophylaxis group

    Group will consist of patients meeting the inclusion criteria and : * in whom systemic intravenous antibiotic prophylaxis has been initiated within 24 hours of the start of medical management * with a duration of systemic antibiotic prophylaxis of between 24h and 72h

  • Control group

    The group will be made up of patients meeting the inclusion criteria and : \- in whom no systemic antibiotic prophylaxis (apart from any intraoperative antibiotic prophylaxis) was administered during the first 72 hours after the start of medical care

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
10 September 2025